Feb 17, 2026 03:39PM COMPASS Pathways plc (CMPS) February and March 9 calls active, share price up 29%

Feb 12, 2026 07:52AM LifeSci Capital Starts Compass Pathways (CMPS) at Underperform

Jan 26, 2026 05:34AM COMPASS Pathways plc (CMPS) 3K contracts of March 8 calls trade

Jan 23, 2026 06:09AM Compass Pathways (CMPS) PT Raised to $21 at RBC Capital

Jan 8, 2026 07:50AM Compass Pathways (CMPS) Reiterated at Buy by Stifel Post COMP360 Event

Jan 8, 2026 07:47AM Compass Pathways (CMPS) Reiterated at Market Outperform by Cantor Fitzgerald

Jan 7, 2026 06:42AM Compass Pathways Announces FDA Acceptance of IND Application for PTSD

Jan 6, 2026 06:30AM Compass Pathways partners with Radial Health for mental health delivery

Dec 9, 2025 04:12PM Oppenheimer Upgrades Compass Pathways (CMPS) to Outperform

Dec 8, 2025 02:21PM COMPASS Pathways plc (CMPS) call put ratio 9.9 calls to 1 put with a focus on January 12 calls as share price up 7.7%

Nov 4, 2025 06:35AM COMPASS Pathways plc (CMPS) Misses Q3 EPS by 104c

Sep 10, 2025 09:16AM RBC Capital on Biotech: 'Who Wins and Who Loses If RFK, Jr. Goes'

Aug 5, 2025 06:44AM Compass Pathways (CMPS) PT Lowered to $40 at H.C. Wainwright

Jul 31, 2025 06:36AM COMPASS Pathways plc (CMPS) Tops Q2 EPS by 1c

Jun 24, 2025 06:51AM H.C. Wainwright Reiterates Buy Rating on Compass Pathways (CMPS)

Jun 24, 2025 05:27AM Compass Pathways (CMPS) PT Lowered to $7 at BTIG

Jun 23, 2025 09:14AM Evercore ISI Downgrades Compass Pathways (CMPS) to In Line

Jun 23, 2025 06:30AM COMPASS Pathways plc (CMPS) Achieves Primary Endpoint in First Phase 3 Trial of COMP360

May 27, 2025 09:27AM TD Cowen Reiterates Buy Rating on Compass Pathways (CMPS)

May 8, 2025 06:36AM COMPASS Pathways plc (CMPS) Tops Q1 EPS by 24c

Apr 11, 2025 07:09AM Stifel Reiterates Buy Rating on Compass Pathways (CMPS)

Apr 2, 2025 07:04AM Smid cap biotech investors must stop chasing binary events says Cantor Fitzgerald

Mar 28, 2025 06:53AM Cantor Fitzgerald Reiterates Overweight Rating on Compass Pathways (CMPS)

Mar 18, 2025 06:30AM COMPASS Pathways plc (CMPS) Announces Publication of Results from COMP004 Study on COMP360 Psilocybin

Mar 5, 2025 06:52AM H.C. Wainwright Reiterates Buy Rating on Compass Pathways (CMPS)

Feb 28, 2025 06:54AM Compass Pathways (CMPS) PT Lowered to $15 at Canaccord Genuity

Feb 27, 2025 06:32AM COMPASS Pathways plc (CMPS) Reports In-Line Q4 EPS

Feb 26, 2025 04:06PM Stifel Starts Compass Pathways (CMPS) at Buy

Feb 13, 2025 06:49AM Compass Pathways (CMPS) PT Lowered to $45 at H.C. Wainwright

Jan 29, 2025 09:12AM Cantor Fitzgerald provides update on Biotechnology stocks

Jan 27, 2025 06:58AM Compass Pathways (CMPS) PT Lowered to $9 at Rodman & Renshaw

Jan 21, 2025 06:32AM COMPASS Pathways plc (CMPS) Appoints Steve Levine as Chief Patient Officer

Jan 10, 2025 07:03AM COMPASS Pathways plc (CMPS) prices 24M ADS at $5.796

Dec 18, 2024 06:30AM COMPASS Pathways plc (CMPS) to Join NASDAQ Biotechnology Index (NBI)

Nov 11, 2024 07:13AM Compass Pathways (CMPS) PT Lowered to $23 at Canaccord Genuity

Nov 4, 2024 06:47AM Compass Pathways (CMPS) PT Lowered to $60 at H.C. Wainwright

Nov 1, 2024 06:20AM Compass Pathways (CMPS) PT Lowered to $18 at RBC Capital

Oct 31, 2024 06:36AM COMPASS Pathways plc (CMPS) Tops Q3 EPS by 1c

Aug 13, 2024 09:41AM TD Cowen Reiterates Buy Rating on Compass Pathways (CMPS)

Aug 2, 2024 09:15AM Compass Pathways (CMPS) PT Lowered to $48 at Canaccord Genuity

Aug 1, 2024 08:44AM COMPASS Pathways plc (CMPS) Misses Q2 EPS by 3c

Jul 23, 2024 03:16AM RBC Capital Starts Compass Pathways (CMPS) at Outperform

Jul 22, 2024 04:24PM RBC Capital Starts Compass Pathways (CMPS) at Outperform

Jun 26, 2024 06:31AM COMPASS Pathways plc (CMPS) Appoints Lori Englebert as Chief Commercial Officer